Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel

MarketBeat Instant News Alerts

Adaptive Biotechnologies logo with Healthcare background

152,500 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Perceptive Advisors LLC

MarketBeat

Perceptive Advisors LLC bought a new stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 152,500 shares of

NASDAQ:ADPT
Read 152,500 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Perceptive Advisors LLC
Crescent Biopharma logo with Healthcare background

Perceptive Advisors LLC Lowers Stake in Crescent Biopharma, Inc. $CBIO

MarketBeat

Perceptive Advisors LLC cut its holdings in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) by 54.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 206,942 shares of the biopharmaceutical company's stock after selling 246,744

NASDAQ:CBIO
Read Perceptive Advisors LLC Lowers Stake in Crescent Biopharma, Inc. $CBIO
ADMA Biologics logo with Healthcare background

Perceptive Advisors LLC Lowers Position in ADMA Biologics Inc $ADMA

MarketBeat

Perceptive Advisors LLC cut its position in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 47.1% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 467,233 shares of the biotechnology company'

NASDAQ:ADMA
Read Perceptive Advisors LLC Lowers Position in ADMA Biologics Inc $ADMA
Neurocrine Biosciences logo with Healthcare background

Perceptive Advisors LLC Sells 266,000 Shares of Neurocrine Biosciences, Inc. $NBIX

MarketBeat

Perceptive Advisors LLC trimmed its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 80.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 65,050 shares of the company's st

NASDAQ:NBIX
Read Perceptive Advisors LLC Sells 266,000 Shares of Neurocrine Biosciences, Inc. $NBIX
Omada Health logo with Healthcare background

Omada Health, Inc. $OMDA Shares Sold by Perceptive Advisors LLC

MarketBeat

Perceptive Advisors LLC lessened its stake in Omada Health, Inc. (NASDAQ:OMDA - Free Report) by 67.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 786,330 shares of the company's stock after selling 1,610,000 shares during the period. Perceptive Advisors LLC

NASDAQ:OMDA
Read Omada Health, Inc. $OMDA Shares Sold by Perceptive Advisors LLC
Neumora Therapeutics logo with Healthcare background

Perceptive Advisors LLC Takes $9.95 Million Position in Neumora Therapeutics, Inc. $NMRA

MarketBeat

Perceptive Advisors LLC acquired a new stake in shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 5,104,097 shares of the company's stock, valued at a

NASDAQ:NMRA
Read Perceptive Advisors LLC Takes $9.95 Million Position in Neumora Therapeutics, Inc. $NMRA

Trending News

1Situational Awareness LP Buys 2,998,214 Shares of IREN Limited $IREN
2Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD Securities
3Southpoint Capital Advisors LP Buys 300,000 Shares of Advanced Micro Devices, Inc. $AMD
4Brokers Offer Predictions for Nokia's Q3 Earnings (NYSE:NOK)
5Advanced Micro Devices (AMD) to Post Earnings on Tuesday
6IREN (NASDAQ:IREN) Stock Price Down 13.6% - Time to Sell?
7Tesla (NASDAQ:TSLA) Shares Down 3% - Here's Why
8Bloom Energy (NYSE:BE) Shares Gap Down - Should You Sell?

All MarketBeat Instant News Alerts

Phathom Pharmaceuticals logo with Healthcare background

925,000 Shares in Phathom Pharmaceuticals, Inc. $PHAT Purchased by Perceptive Advisors LLC

MarketBeat
NASDAQ:PHAT
Read 925,000 Shares in Phathom Pharmaceuticals, Inc. $PHAT Purchased by Perceptive Advisors LLC
Evommune logo with Healthcare background

Perceptive Advisors LLC Buys Shares of 448,350 Evommune, Inc. $EVMN

MarketBeat
NYSE:EVMN
Read Perceptive Advisors LLC Buys Shares of 448,350 Evommune, Inc. $EVMN
Palisade Bio logo with Healthcare background

Perceptive Advisors LLC Has $15.62 Million Stake in Palisade Bio, Inc. $PALI

MarketBeat
NASDAQ:PALI
Read Perceptive Advisors LLC Has $15.62 Million Stake in Palisade Bio, Inc. $PALI
Contineum Therapeutics logo with Healthcare background

Perceptive Advisors LLC Has $16.40 Million Stake in Contineum Therapeutics, Inc. $CTNM

MarketBeat
NASDAQ:CTNM
Read Perceptive Advisors LLC Has $16.40 Million Stake in Contineum Therapeutics, Inc. $CTNM
Sutro Biopharma logo with Healthcare background

Perceptive Advisors LLC Invests $17.82 Million in Sutro Biopharma, Inc. $STRO

MarketBeat
NASDAQ:STRO
Read Perceptive Advisors LLC Invests $17.82 Million in Sutro Biopharma, Inc. $STRO
DBV Technologies logo with Healthcare background

Perceptive Advisors LLC Invests $20.15 Million in DBV Technologies S.A. $DBVT

MarketBeat
NASDAQ:DBVT
Read Perceptive Advisors LLC Invests $20.15 Million in DBV Technologies S.A. $DBVT
Viridian Therapeutics logo with Healthcare background

Viridian Therapeutics, Inc. $VRDN Shares Sold by Perceptive Advisors LLC

MarketBeat
NASDAQ:VRDN
Read Viridian Therapeutics, Inc. $VRDN Shares Sold by Perceptive Advisors LLC
Tenax Therapeutics logo with Healthcare background

Perceptive Advisors LLC Raises Stock Holdings in Tenax Therapeutics, Inc. $TENX

MarketBeat
NASDAQ:TENX
Read Perceptive Advisors LLC Raises Stock Holdings in Tenax Therapeutics, Inc. $TENX
SAB Biotherapeutics logo with Healthcare background

Perceptive Advisors LLC Buys 5,628,533 Shares of SAB Biotherapeutics, Inc. $SABS

MarketBeat
NASDAQ:SABS
Read Perceptive Advisors LLC Buys 5,628,533 Shares of SAB Biotherapeutics, Inc. $SABS
Revolution Medicines logo with Healthcare background

Perceptive Advisors LLC Purchases New Position in Revolution Medicines, Inc. $RVMD

MarketBeat
NASDAQ:RVMD
Read Perceptive Advisors LLC Purchases New Position in Revolution Medicines, Inc. $RVMD
Sionna Therapeutics logo with Healthcare background

Perceptive Advisors LLC Decreases Position in Sionna Therapeutics, Inc. $SION

MarketBeat
NASDAQ:SION
Read Perceptive Advisors LLC Decreases Position in Sionna Therapeutics, Inc. $SION
Bright Minds Biosciences logo with Healthcare background

Perceptive Advisors LLC Sells 71,746 Shares of Bright Minds Biosciences Inc. $DRUG

MarketBeat
NASDAQ:DRUG
Read Perceptive Advisors LLC Sells 71,746 Shares of Bright Minds Biosciences Inc. $DRUG
Guardant Health logo with Healthcare background

Guardant Health, Inc. $GH Shares Acquired by Perceptive Advisors LLC

MarketBeat
NASDAQ:GH
Read Guardant Health, Inc. $GH Shares Acquired by Perceptive Advisors LLC
X4 Pharmaceuticals logo with Healthcare background

Perceptive Advisors LLC Increases Stake in X4 Pharmaceuticals, Inc. $XFOR

MarketBeat
NASDAQ:XFOR
Read Perceptive Advisors LLC Increases Stake in X4 Pharmaceuticals, Inc. $XFOR
Repligen logo with Healthcare background

Perceptive Advisors LLC Cuts Stock Holdings in Repligen Corporation $RGEN

MarketBeat
NASDAQ:RGEN
Read Perceptive Advisors LLC Cuts Stock Holdings in Repligen Corporation $RGEN
Corvus Pharmaceuticals logo with Healthcare background

Perceptive Advisors LLC Has $33.54 Million Holdings in Corvus Pharmaceuticals, Inc. $CRVS

MarketBeat
NASDAQ:CRVS
Read Perceptive Advisors LLC Has $33.54 Million Holdings in Corvus Pharmaceuticals, Inc. $CRVS
Immunovant logo with Healthcare background

Perceptive Advisors LLC Lowers Stake in Immunovant, Inc. $IMVT

MarketBeat
NASDAQ:IMVT
Read Perceptive Advisors LLC Lowers Stake in Immunovant, Inc. $IMVT
Alto Neuroscience logo with Healthcare background

Perceptive Advisors LLC Buys 225,500 Shares of Alto Neuroscience, Inc. $ANRO

MarketBeat
NYSE:ANRO
Read Perceptive Advisors LLC Buys 225,500 Shares of Alto Neuroscience, Inc. $ANRO
CytomX Therapeutics logo with Healthcare background

CytomX Therapeutics, Inc. $CTMX Shares Bought by Perceptive Advisors LLC

MarketBeat
NASDAQ:CTMX
Read CytomX Therapeutics, Inc. $CTMX Shares Bought by Perceptive Advisors LLC
Artivion logo with Healthcare background

Perceptive Advisors LLC Sells 85,000 Shares of Artivion, Inc. $AORT

MarketBeat
NYSE:AORT
Read Perceptive Advisors LLC Sells 85,000 Shares of Artivion, Inc. $AORT
Oruka Therapeutics logo with Healthcare background

Perceptive Advisors LLC Sells 81,000 Shares of Oruka Therapeutics, Inc. $ORKA

MarketBeat
NASDAQ:ORKA
Read Perceptive Advisors LLC Sells 81,000 Shares of Oruka Therapeutics, Inc. $ORKA
BioCryst Pharmaceuticals logo with Healthcare background

Perceptive Advisors LLC Acquires 4,271,504 Shares of BioCryst Pharmaceuticals, Inc. $BCRX

MarketBeat
NASDAQ:BCRX
Read Perceptive Advisors LLC Acquires 4,271,504 Shares of BioCryst Pharmaceuticals, Inc. $BCRX
Dyne Therapeutics logo with Healthcare background

Dyne Therapeutics, Inc. $DYN Shares Purchased by Perceptive Advisors LLC

MarketBeat
NASDAQ:DYN
Read Dyne Therapeutics, Inc. $DYN Shares Purchased by Perceptive Advisors LLC
Travere Therapeutics logo with Healthcare background

Perceptive Advisors LLC Sells 135,629 Shares of Travere Therapeutics, Inc. $TVTX

MarketBeat
NASDAQ:TVTX
Read Perceptive Advisors LLC Sells 135,629 Shares of Travere Therapeutics, Inc. $TVTX

Featured Articles and Offers

RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
By Dan Schmidt | July 26, 2026
tc pixel
1 Stock to Own by July 31st
1 Stock to Own by July 31st
From Chaikin Analytics (Ad)
AMD’s AI Bubble Could Burst Into Explosive Upside
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
By Nathan Reiff | July 28, 2026
Why SK hynix Could Be the Best AI Chip Stock to Buy Now
Why SK hynix Could Be the Best AI Chip Stock to Buy Now
By Thomas Hughes | July 29, 2026
tc pixel
Your book attached
Your book attached
From Profits Run (Ad)
AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
By Thomas Hughes | July 27, 2026
Broadcom May Be the Biggest Winner From Alphabet's Earnings
Broadcom May Be the Biggest Winner From Alphabet's Earnings
By Leo Miller | July 26, 2026

Alert Categories

All Alerts
Page 1 of 707